Latest news
Generic drug manufacturer Sandoz agrees to $400 million settlement over allegations of scheme to inflate prescription prices, limit competition - nottinghammd.comnottinghammd.com · Fri, 07 Aug 2026 10:30:00 GMTSandoz takes further steps to resolve legacy U.S. generic medicine litigation - Drug Store NewsDrug Store News · Thu, 06 Aug 2026 13:37:43 GMTRx Rundown: Supernus Pharmaceuticals, TCGX, Sandoz and more - Medical Marketing and MediaMedical Marketing and Media · Thu, 06 Aug 2026 13:33:55 GMTSandoz Earns ‘Blue Chip’ Status With Biosimilars Growth And GLP-1 Opportunity - insights.citeline.cominsights.citeline.com · Thu, 06 Aug 2026 10:30:54 GMTSandoz Inc. agrees to $469M settlement in generic drug price-fixing case, Tong says - Norwalk HourNorwalk Hour · Thu, 06 Aug 2026 09:07:38 GMTAG Drummond announces $469 million settlement with Sandoz over drug pricing scheme - KFORKFOR · Wed, 05 Aug 2026 17:44:07 GMTSandoz Group AG (SDZNY) (H1 2026) Earnings Call Highlights: Biosimilar Growth Drives 5% Sales ... - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 15:01:24 GMTSandoz in Talks With U.S. Government About Potential Investment, CEO Says - WSJWSJ · Wed, 05 Aug 2026 14:03:00 GMT